Walk-in-interview in Glenmark for the Sales Positions | Mumbai, Bangalore, Delhi
Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.

British Biologicals, a growing giant among Indian Nutraceutical companies currently exports to the South East Asia, the Middle East, East Africa and West Indies and also venturing towards the European and American markets.
